The clearance of Tryngolza gives Ionis its first wholly-owned, marketed medicine. Elsewhere, Robert Temple became the latest ...
Merck & Co. Inc. 1.22% $248.76B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback